Cargando…
ENO1 and Cancer
α-Enolase (ENO1), also known as 2-phospho-D-glycerate hydrolase, is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglyceric acid to phosphoenolpyruvic acid during glycolysis. It is a multifunctional oncoprotein that is present both in cell surface and cytoplasm, contributing to hit se...
Autores principales: | Huang, Chen Kai, Sun, Ying, Lv, Lei, Ping, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987341/ https://www.ncbi.nlm.nih.gov/pubmed/35434271 http://dx.doi.org/10.1016/j.omto.2021.12.026 |
Ejemplares similares
-
Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer
por: Huang, Zhengnan, et al.
Publicado: (2022) -
Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer
por: Song, Qingru, et al.
Publicado: (2023) -
CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1
por: Zhou, Jiayu, et al.
Publicado: (2019) -
mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling
por: Wang, Yiying, et al.
Publicado: (2022) -
ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
por: Yin, Hang, et al.
Publicado: (2018)